Document Detail


The impact of topiramate (Topamax®) therapy on the development of aggressive and/or agitated behavior.
MedLine Citation:
PMID:  21987528     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The use of topiramate therapy to control the neuropsychiatric and behavioral disturbances in individuals with mental and/or developmental disabilities with co-occurring psychiatric disturbances has become a standard of practice in many long-term care assisted living facilities. With increased utilization of this anticonvulsant, there has been a rise in the number documented cases of agitation and/or aggressive behavior associated with topiramate therapy. It is the purpose of this article to explore the current literature documenting the connection between topiramate utilization and the development of aggressive and/or agitated behavior.
Authors:
Abimbola Farinde
Related Documents :
8803598 - Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer.
23099178 - Update on the treatment of superficial mycoses.
18064688 - False-positive interpretations in respiratory cytopathology: exemplary cases and litera...
11454998 - Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.
8772028 - Isolated collagenoma: a case report with a review of connective tissue nevi of the coll...
18207558 - Sphenoid wing inflammatory pseudotumor mimicking a clinoidal meningioma: case report an...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2011-10-10
Journal Detail:
Title:  Journal of pharmacy practice     Volume:  24     ISSN:  1531-1937     ISO Abbreviation:  J Pharm Pract     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2012-01-18     Completed Date:  2012-05-04     Revised Date:  2013-08-21    
Medline Journal Info:
Nlm Unique ID:  8900945     Medline TA:  J Pharm Pract     Country:  United States    
Other Details:
Languages:  eng     Pagination:  568-70     Citation Subset:  IM    
Affiliation:
Lufkin State Supported Living Center, Nacogdoches, TX 75965, USA. aofpharm420@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aggression / psychology*
Anticonvulsants / adverse effects*
Epilepsy / drug therapy*
Fructose / adverse effects,  analogs & derivatives*
Humans
Male
Mental Disorders / chemically induced*
Psychomotor Agitation / etiology*,  psychology
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0H73WJJ391/topiramate; 30237-26-4/Fructose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparative Effectiveness of Dalteparin and Enoxaparin in a Hospital Setting.
Next Document:  A Cost-Effectiveness Evaluation of Hospital Discharge Counseling by Pharmacists.